Allina Health System dba Virginia Piper Cancer Institute

Minneapolis, Minnesota 55407

1 studies enrolling now · 4 studies all time

What they study most

ATC, Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial, Breast Cancer, CRC, Melanoma, Metastatic Breast Cancer, NSCLC, Solid Tumors

Studies at this site

• Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation — Recruiting now
• A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors — Completed
• Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer — Completed
• Registry Study for Talimogene Laherparepvec — Completed